CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
1.890
+0.080 (4.42%)
At close: Aug 13, 2025, 4:00 PM
1.830
-0.060 (-3.17%)
After-hours: Aug 13, 2025, 4:10 PM EDT
CASI Pharmaceuticals Employees
CASI Pharmaceuticals had 233 employees as of December 31, 2024. The number of employees increased by 57 or 32.39% compared to the previous year.
Employees
233
Change (1Y)
57
Growth (1Y)
32.39%
Revenue / Employee
$134,627
Profits / Employee
-$173,734
Market Cap
29.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CASI News
- 9 days ago - CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR) - Accesswire
- 23 days ago - CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer to Lead U.S. Company Focused on Clinical Development of CID-103, a Potential Best in Class Anti-CD38 Program - Accesswire
- 3 months ago - CASI Pharmaceuticals Provides Business and Clinical Update - Accesswire
- 3 months ago - CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results - Accesswire
- 3 months ago - CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China - Accesswire
- 3 months ago - CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement - Accesswire
- 4 months ago - CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company - Accesswire
- 4 months ago - CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results - Accesswire